Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis: A prospective cohort study-Reference-Cited by-同舟云学术

Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis: A prospective cohort study

Published:2017-06 Issue:6 Volume:46 Page:732-739
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Aaltonen Kalle,Heinonen Arto,Joensuu Jaana,Parmanne Pinja,Karjalainen Anna,Varjolahti-Lehtinen Tuire,Uutela Toini,Puurtinen-Vilkki Maija,Arstila Leena,Blom Marja,Sokka Tuulikki,Nordström Dan

Funder

Finska Läkaresällskapet

Emil Aaltonen

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference19 articles.

1. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update;Gossec;Ann Rheum Dis,2015

2. A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis;Ash;Ann Rheum Dis,2012

3. Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry;Glintborg;Arthritis Rheum,2011

4. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register;Kristensen;Ann Rheum Dis,2008

5. Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register;Saad;Arthritis Res Ther,2009

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Drug Survival of Biologics and Targeted Synthetic Disease-Modifying Anti-rheumatic Drugs Among Patients with Psoriatic Arthritis;Drugs & Aging;2024-08

2. Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment;Joint Bone Spine;2024-07

3. No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registry;RMD Open;2024-07

4. Non-trough serum drug levels of adalimumab and etanercept are associated with response in patients with psoriatic arthritis;Rheumatology;2023-12-09

5. Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response;Rheumatology Advances in Practice;2023-12-09